Alushi Kastriot, Hinterseher Irene, Peters Frederik, Rother Ulrich, Bischoff Moritz S, Mylonas Spyridon, Grambow Eberhard, Gombert Alexander, Busch Albert, Gray Daphne, Konstantinou Nikolaos, Stavroulakis Konstantinos, Horn Marco, Görtz Hartmut, Uhl Christian, Federrath Hannes, Trute Hans-Heinrich, Kreutzburg Thea, Behrendt Christian-Alexander
Research Group GermanVasc, Department of Vascular Medicine, University Heart and Vascular Centre UKE Hamburg, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.
Berlin Institute of Health, Vascular Surgery Clinic, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
J Clin Med. 2022 Jan 19;11(3):498. doi: 10.3390/jcm11030498.
Broadly available digital and mobile health applications (also known as mHealth) have recently gained increasing attention by the vascular community, but very little is known about the dissemination and acceptance of such technologies in certain target populations. The current study aimed to determine the user behaviour and acceptance of such digital technologies amongst patients with peripheral arterial disease (PAD).
A cross-sectional survey of consecutively treated inpatients at 12 university institutions, as well as one non-university institution, was conducted. All admitted patients with symptomatic PAD were surveyed for 30 consecutive days within a flexible timeframe between 1 July and 30 September 2021. The factors associated with smartphone use were estimated via backward selection within a logistic regression model with clustered standard errors.
A total of 326 patients participated (response rate 96.3%), thereof 102 (34.0%) were treated for intermittent claudication (IC, 29.2% women, 70 years in median) and 198 were treated for chronic limb-threatening ischaemia (CLTI, 29.5% women, 70 years in median). Amongst all of the patients, 46.6% stated that they had not changed their lifestyle and health behaviour since the index diagnosis (four years in median), and 33.1% responded that they were not aware of the reasons for all of their medication orders. Amongst all those surveyed, 66.8% owned a smartphone (IC: 70.6%, CLTI: 64.1%), thereof 27.9% needed regular user support. While 42.5% used smartphone apps, only 15.0% used mobile health applications, and 19.0% owned wearables. One out of five patients agreed that such technologies could help to improve their healthy lifestyle. Only higher age was inversely associated with smartphone possession.
The current survey showed that smartphones are prevalent amongst patients with peripheral arterial disease, but only a small proportion used mobile health applications and a considerable number of patients needed regular user support. Almost half of the patients did not change their lifestyle and one third were not aware of the reasons for their medication orders, emphasising room for improvement. These findings can further help to guide future projects using such applications to identify those target populations that are reachable with digital interventions.
广泛可用的数字和移动健康应用程序（也称为移动医疗）最近越来越受到血管领域的关注，但对于这些技术在某些目标人群中的传播和接受情况知之甚少。当前研究旨在确定外周动脉疾病（PAD）患者对这类数字技术的使用行为和接受程度。
对12所大学机构以及1所非大学机构中连续接受治疗的住院患者进行了横断面调查。在2021年7月1日至9月30日的灵活时间段内，对所有入院的有症状PAD患者连续30天进行调查。通过在具有聚类标准误差的逻辑回归模型中进行向后选择，估计与智能手机使用相关的因素。
共有326名患者参与（应答率96.3%），其中102名（34.0%）接受间歇性跛行（IC）治疗（女性占29.2%，中位年龄70岁），198名接受慢性肢体威胁性缺血（CLTI）治疗（女性占29.5%，中位年龄70岁）。在所有患者中，46.6%表示自索引诊断以来（中位时间为四年）他们的生活方式和健康行为没有改变，33.1%回答他们不知道所有药物医嘱的原因。在所有接受调查的人中，66.8%拥有智能手机（IC：70.6%，CLTI：64.1%），其中27.9%需要定期用户支持。虽然42.5%使用智能手机应用程序，但只有15.0%使用移动健康应用程序，19.0%拥有可穿戴设备。五分之一的患者同意这类技术有助于改善他们的健康生活方式。只有年龄较大与拥有智能手机呈负相关。
当前调查显示，智能手机在外周动脉疾病患者中很普遍，但只有一小部分人使用移动健康应用程序，相当数量的患者需要定期用户支持。几乎一半的患者没有改变他们的生活方式，三分之一的患者不知道他们药物医嘱的原因，这突出了改进的空间。这些发现可以进一步帮助指导未来使用此类应用程序的项目，以确定那些可通过数字干预触及的目标人群。
